Vicarious Surgical (RBOT) Research & Development (2020 - 2025)
Vicarious Surgical (RBOT) posted quarterly Research & Development of $8.0 million for Q3 2025, down 25.99% year-over-year from $10.8 million in Q3 2024, and down 11.68% quarter-over-quarter from $9.0 million in Q2 2025.
Vicarious Surgical (RBOT) Research & Development (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Research & Development for 6 consecutive years, with $8.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Research & Development fell 25.99% year-over-year to $8.0 million; the TTM figure through Sep 2025 stood at $34.9 million (down 13.05% YoY), while the FY2024 annual figure was $40.2 million, down 15.6% from the prior year.
- Research & Development eased to $8.0 million in Q3 2025 per RBOT's latest filing, from $9.0 million in the prior quarter.
- Across five years, Research & Development topped out at $13.4 million in Q1 2023 and bottomed at $3.6 million in Q1 2021.
- Historically, Research & Development has averaged $9.5 million across 5 years, with a median of $9.8 million in 2022.
- Annual changes were most pronounced in 2021 — Research & Development surged 212.14% — and 2023, when it slipped 28.7%.
- Vicarious Surgical's Research & Development stood at $9.3 million in 2021, then grew by 28.33% to $11.9 million in 2022, then fell by 28.7% to $8.5 million in 2023, then dropped by 0.06% to $8.5 million in 2024, then retreated by 5.55% to $8.0 million in 2025.
- Business Quant data shows RBOT's Research & Development at $8.0 million in Q3 2025, $9.0 million in Q2 2025, and $9.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Vicarious Surgical | 220,312.99 | -14.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 7.99 Mn |
| Jun 30, 2025 | 9.05 Mn |
| Mar 31, 2025 | 9.42 Mn |
| Dec 31, 2024 | 8.46 Mn |
| Sep 30, 2024 | 10.80 Mn |
| Jun 30, 2024 | 10.92 Mn |
| Mar 31, 2024 | 9.97 Mn |
| Dec 31, 2023 | 8.47 Mn |
| Sep 30, 2023 | 13.04 Mn |
| Jun 30, 2023 | 12.71 Mn |
| Mar 31, 2023 | 13.36 Mn |
| Dec 31, 2022 | 11.88 Mn |
| Sep 30, 2022 | 12.12 Mn |
| Jun 30, 2022 | 10.06 Mn |
| Mar 31, 2022 | 9.85 Mn |
| Dec 31, 2021 | 9.26 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 4.01 Mn |
| Mar 31, 2021 | 3.61 Mn |
| Dec 31, 2020 | 2.97 Mn |